Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NIH-funded Institutional Training Programs in Colleges and Schools of Pharmacy.

American journal of pharmaceutical education·2026
Same author

Generative artificial intelligence tools as an aid for pharmacy career preparation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

The preceptor-learner care process: Applying person-centered thinking in pharmacy education.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

The Effect of Transesophageal Echocardiogram on Clinical Outcomes for Patients with <i>Staphylococcus aureus</i> Bloodstream Infection.

Antibiotics (Basel, Switzerland)·2026
Same author

The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us.

JHLT open·2026
Same author

Transplacental transfer efficiency of environmental chemicals in association with gestational diabetes mellitus.

Environment international·2025

Related Experiment Video

Updated: May 23, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Artemether-lumefantrine: an option for malaria.

Kayla R Stover1, S Travis King, Jessica Robinson

  • 1School of Pharmacy, University of Mississippi, Jackson, MS, USA. kstover@umc.edu

The Annals of Pharmacotherapy
|April 13, 2012
PubMed
Summary

Artemether-lumefantrine is a safe and effective treatment for Plasmodium falciparum malaria in all age groups. This artemisinin-based combination therapy demonstrates high cure rates and mild side effects, making it a valuable option for malaria treatment.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Detection and Quantification of Plasmodium falciparum in Aqueous Red Blood Cells by Attenuated Total Reflection Infrared Spectroscopy and Multivariate Data Analysis
10:50

Detection and Quantification of Plasmodium falciparum in Aqueous Red Blood Cells by Attenuated Total Reflection Infrared Spectroscopy and Multivariate Data Analysis

Published on: November 2, 2018

Related Experiment Videos

Last Updated: May 23, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Detection and Quantification of Plasmodium falciparum in Aqueous Red Blood Cells by Attenuated Total Reflection Infrared Spectroscopy and Multivariate Data Analysis
10:50

Detection and Quantification of Plasmodium falciparum in Aqueous Red Blood Cells by Attenuated Total Reflection Infrared Spectroscopy and Multivariate Data Analysis

Published on: November 2, 2018

Area of Science:

  • Pharmacology and Tropical Medicine
  • Infectious Diseases
  • Drug Efficacy Studies

Background:

  • Plasmodium falciparum malaria remains a significant global health challenge.
  • Artemisinin-based combination therapies (ACTs) are frontline treatments for malaria.
  • Artemether-lumefantrine (AL) is an FDA-approved ACT for P. falciparum malaria.

Purpose of the Study:

  • To review the pharmacology, pharmacokinetics, safety, and efficacy of artemether-lumefantrine.
  • To evaluate AL's effectiveness in treating P. falciparum malaria.
  • To compare AL's efficacy and safety against other antimalarial treatments.

Main Methods:

  • Systematic review of English-language articles from PubMed (1947-November 2011).
  • Inclusion of WHO and CDC malaria treatment guidelines.
  • Search terms included artemether-lumefantrine, Coartem, and malaria.

Main Results:

  • Artemether-lumefantrine offers dual mechanisms for rapid and sustained parasite clearance.
  • Polymerase chain reaction (PCR)-corrected cure rates for AL were noninferior to comparators (28-day: 86-100% vs 51-100%; 42-day: 92-99.3% vs 62-100%).
  • Adverse effects were generally mild to moderate; adherence challenges were noted but clinical cure rates were comparable.

Conclusions:

  • Artemether-lumefantrine is a safe and effective antimalarial treatment.
  • It is suitable for both children and adults with P. falciparum malaria.
  • AL provides a valuable therapeutic option for malaria management.